90/IV 7 x G' 6X 13' 2 X 13" We have found t h a t a glycoprotein in the cell surface of the Ha subline of the ascites form of TA3 mouse m a m m a r y adenocarcinoma is closely related to the h u m a n blood group N antigen [1]. This was the first description of a cross-reacting antigen within the blood group MN system in a lower animal as well as a tumor. N and tumor antigens possess extremely high and specific Vicia grarninea-agglutinin inhibitory activity and both have Gal and N A N A as termini [2] [3] [4] . Intact TA3 carcinoma cells of both the strain-specific St and especially the non-strain-specific, much more invasive, His subline (cf. [5] ) absorbed Vicia graminea, Arachis hypogaea and anti-pneumococcus Type X I V agglutinins which all possess anti-fl-D-Gal specificity [6, 7] . The serological specificity of both the plant agglutinins is closely related to that of the anti-T agglutinin oI Thomsen mad Friedenreich [8, 9] which like anti-Tn (see below) occurs in the sera of all adult humans. H u m a n anti-T in the presence of complement killed the TA3-St cells while the TA3-Ha cells were completely resistant, b u t the latter became fully susceptible after removal of their terminal NANA by sialidase (RDE). If there was a concomitant t r e a t m e n t with fl-D-galactosidase, the killing activity of h u m a n and other mammalian sera on both sublines of t u m o r ceils was abolished [6, 7] . We have now found by absorption studies t h a t membranes from all 3 non-malignant h u m a n breast glands, and frmn 3 primary in situ, and 9 grossly malignant breast lesions tested possessed blood group M, N and Vicia active substances and t h a t the Thomsen-Friedenreich T antigen was demonstrable in chemically untreated malignant but not in normal tissues or benign lesions.
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The membrane-cytoplasm preparations of benign as well as malignant breast gland tissues extensively absorbed anti-M and anti-N from most human antisera compatible with the representation of the antigens on the red cells of the individuals from whom the breast tissue was obtained. Absorption of rabbit anti-N and anti-M sera usually resulted in lesser decrease of antibodies and some membrane preparations were not effective. Arachis hypogaea activity was clearly absorbed by all malignancies and to a lesser extent by membranes from healthy mammary glands and benign lesions. The T antigen was demonstrable in all membranes from the malignancies; 3 calmer patients of blood group 0 with weakly expressed T antigen possessed Tn as measured with human anti-Tn but not with Salvia sp. extract. The occurrence of blood group M and N specific macromolecules in healthy as well as malignant mammary gland tissue which had been carefully freed of blood before work-up is of interest. The discovery of immediate precursor substances of these antigens [10- 131Iodo-deoxyuridine {lalUdR) can be incorporated instead of thymidine into the DNA of tumors. The use of this isotope in tumor detection, however, is complicated by its possible incorporation in other proliferating cells. This means that the positive detection of a tumor depends on faster incorporation into the tumor than into other organs. A further complication is that only a small percentage of the lalIUdlR applied is actually incorporated into the DNA (4-5% for rats). The remainder is liberated as 181iodide and can interfere with scintigraphic measurements. Since the biological half-life of laiodide in rats is t2 h, the incorporated 131IUdR can only be determined after about 48 h. During this time, the activity in the tumor is reduced by such processes as disintegration of laiodide, repair mechanisms, and the death of labeled cells. Since a further increase in the dose of radioactive substance used is excluded because of the radiation level, we have attempted to increase the incorporation of 181IUdR by other means.
Using hydroxyurea for synchronization, we were able to increase the incorporation of lalUdR into a slow-growing, transplanted neurosarcoma of the rat by a factor of 2.5 [tl. This facilitated the scintigraphic detection of appreciably smaller tumors. We also attempted to increase the radioactivity in the tumor by binding a labeled nucleotide to a strongly basic protein (protamin-131iodo-deoxycytidine monophosphate) [21, but this method did not lead to any appreciable increase in incorporation. Therefore we tried a biological carrier in a similar experiment. Spores of anaerobes germinate and multiply selectively in tumors E3-5~, hence we expected clostridia would increase the concentration of latlUdR in the tumor. Thirty hamsters (90 g, $) with amelanotic melanomas (No. 4, Fortner) were treated i.v. with elostridia (Clostridium butyricum 55, 2 • t0 s spores per animal) 7 days after tumor transplantation. A group of 30 tumor-bearing hamsters served as controls. The animals were injected with 131IUdR 24 or 48 h after treatment. Groups of 5 animMs were killed 12, 24 and 48 h after injection of the radioactive precursor, and the activity in the tumor and in 9 other organs was determined by means of a NaI-Tl-scintillation detector.
When lalIUdR was injected 24 h after the clostridia spores, no significant rise in incorporation was observed at any subsequent time; when it was given 48 h after spore injection, the activity in the tumors was increased by a factor of 2 (p < 0.05). The activity in the other organs was similar in treated and control animals (Fig. I) . It can therefore be concluded that clostridia spores, which germinate and multiply selectively in tumors, can be used to promote the amount of lallUdR in the tumor. The increase in activity in the tumor in comparison with other organs might be even higher for slow-growing tumors. Appropriate experiments on slow-growing tumors are presently being carried out in this laboratory. (Fig. 1 ).
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